xaliproden has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bougault, I; Coudé, FX; Fournier, J; Gauthier, T; Guzzi, U; Keane, PE; Le Fur, G; Maffrand, JP; Soubrié, P; Steinberg, R | 1 |
| Borg, J; Duong, F; Fournier, J; Guénet, JL; Keane, PE; Poindron, P; Soubrié, P; Warter, JM | 1 |
2 other study(ies) available for xaliproden and Nerve Degeneration
| Article | Year |
|---|---|
Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates.
Topics: Acetylcholinesterase; Acrylamide; Acrylamides; Animals; Biomarkers; Brain Ischemia; Callithrix; Choline O-Acetyltransferase; Female; Hippocampus; Male; Naphthalenes; Nerve Crush; Nerve Degeneration; Nerve Growth Factors; Nerve Regeneration; Nerve Tissue Proteins; Peripheral Nervous System Diseases; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Sciatic Nerve; Septum Pellucidum; Serotonin Receptor Agonists; Species Specificity; Vincristine | 1993 |
The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse.
Topics: Animals; Animals, Newborn; Electrophysiology; Mice; Mice, Mutant Strains; Motor Activity; Motor Neuron Disease; Motor Neurons; Muscle, Skeletal; Naphthalenes; Nerve Degeneration; Nerve Fibers; Neuroprotective Agents; Pyridines; Sciatic Nerve; Time Factors | 1998 |